To evaluate the potential of Exo‐mRNA and tEV‐mProtein expression as a biomarker for SCLC diagnosis, we assessed DLL3 expression in the 76 clinical SCLC patient and 45 HRS samples listed in Table 1. Here, DLL3 is linked to small cell lung carcinoma.